COMMUNIQUÉS West-GlobeNewswire

Syneos Health Schedules Fourth Quarter and Year End 2017 Earnings Call for Wednesday, February 28, 2018

01/02/2018 - 22:15

RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017 financial results [...]

Kane Biotech Retains Edison Advisors as Investor Relations Counsel

01/02/2018 - 22:14

WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it has retained Edison Advisors (“Edison”), a global [...]

Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A.

01/02/2018 - 22:06

Basel, February 1, 2018 - Novartis AG (NYSE: NVS) today announced the completion of the subsequent offering period of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase all of the outstanding [...]

Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal

01/02/2018 - 22:05

EMERYVILLE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that results of its Phase 2 proof-of-concept clinical trial of ADS-5102 (amantadine) extended release [...]

Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer

01/02/2018 - 22:05

SAINT-GENIS-POUILLY, France, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (“AAA” or the “Company”), a Novartis company and a leader in nuclear medicine theragnostics, today [...]

Actinium Pharmaceuticals Announces Rights Offering

01/02/2018 - 22:05

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that it has filed a preliminary prospectus supplement as a part of a [...]

Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14

01/02/2018 - 22:05

DUBLIN, Ireland, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 9, 2018

01/02/2018 - 22:05

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018

01/02/2018 - 22:05

MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI ) today announced that it will report financial results for the first quarter ended December 31, 2017 on February 8, 2018 [...]

HCi Viocare Comments on Recent Stock Volume and Price Increase

01/02/2018 - 22:01

GLASGOW, SCOTLAND , Feb. 01, 2018 (GLOBE NEWSWIRE) -- HCi Viocare has been advised of a significant increase in the share price and trading volume of the Company's shares beginning Wednesday January 31, 2018. The [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/02/2018 - 22:01

BOSTON, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

athenahealth Reports Fourth Quarter and Full Year 2017 Results

01/02/2018 - 22:01

Q4 2017 Financial Results 14% Revenue Growth Over Fourth Quarter of 2016 GAAP Operating Income of $38.7 million Non-GAAP Adjusted Operating Income of $77.6 million GAAP Net Income of $31.6 million, or $0.78 Per Diluted [...]

CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

01/02/2018 - 22:01

NEWARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors

01/02/2018 - 22:01

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, announced today the [...]

Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

01/02/2018 - 22:00

MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced financial results for its fourth quarter and year ended December 31, 2017. Product, service [...]

Crawford Healthcare Inc. Receives New Innovative Technology Contract from Vizient, Inc. for Touchless Care Zinc Protectant Spray

01/02/2018 - 21:46

DOYLESTOWN, Pa. and CHESHIRE, United Kingdom, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Crawford Healthcare announced its Touchless Care Zinc Protectant Spray has received an Innovative Technology contract from Vizient, Inc . [...]

Alpha Pro Tech, Infection Control Segment, N-95 Facemask Product Availability Update Seasonal Influenza

01/02/2018 - 20:00

Nogales, Ariz., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

CROSSJECT : La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin

01/02/2018 - 19:42

Communiqué de Presse La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin Dijon, le 1 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

HempAmericana Announces Interview Ahead of Full-Scale CBD Oil Production Activity

01/02/2018 - 18:23

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce a new interview with Company CEO, Salvador Rosillo, from Uptick [...]